BridgePort Financial Solutions LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,536 shares of the healthcare conglomerate's stock, valued at approximately $720,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Park Square Financial Group LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $402,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $367,521,000. Brooklyn FI LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $1,392,000. Employees Retirement System of Texas raised its holdings in UnitedHealth Group by 760.2% in the 4th quarter. Employees Retirement System of Texas now owns 238,512 shares of the healthcare conglomerate's stock valued at $120,654,000 after buying an additional 210,786 shares during the period. Finally, Brucke Financial Inc. purchased a new stake in UnitedHealth Group in the 4th quarter valued at about $492,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded up $3.70 during mid-day trading on Friday, hitting $301.87. 10,000,835 shares of the company were exchanged, compared to its average volume of 6,757,339. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a 50 day simple moving average of $435.12 and a 200-day simple moving average of $496.39. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market cap of $273.84 billion, a price-to-earnings ratio of 19.48, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the company posted $6.91 EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on UNH. Truist Financial restated a "buy" rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. HSBC reiterated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Oppenheimer cut their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, Bank of America lowered shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the stock from $560.00 to $350.00 in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $441.87.
View Our Latest Stock Analysis on UNH
Insider Activity
In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by company insiders.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.